Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Szimbólum: 002603.SZ
SHZ
19.58
CNYMai piaci árfolyam
12.0881
P/E arány
0.2763
PEG-arány
32.71B
MRK Cap
- 0.03%
DIV hozam
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603-SZ) Pénzügyi kimutatások
Mérleg
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 5918.12 | 2422.7 | 1050.5 | 1554 | |||||||||||||||
balance-sheet.row.short-term-investments | 960.06 | 518.4 | 55.3 | 217 | |||||||||||||||
balance-sheet.row.net-receivables | 11401.27 | 2699.6 | 2593.1 | 2102.4 | |||||||||||||||
balance-sheet.row.inventory | 9398.48 | 2021.8 | 1672.7 | 1580.3 | |||||||||||||||
balance-sheet.row.other-current-assets | 764.15 | 110.1 | 285.8 | 222.7 | |||||||||||||||
balance-sheet.row.total-current-assets | 27482.02 | 7254.2 | 5602.1 | 5459.4 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 28847.51 | 6221.8 | 5745.5 | 4299.1 | |||||||||||||||
balance-sheet.row.goodwill | 458.41 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.intangible-assets | 1788.73 | 828 | 897.9 | 736.6 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 2247.15 | 828 | 897.9 | 736.6 | |||||||||||||||
balance-sheet.row.long-term-investments | 6697.79 | 830.5 | -54.3 | -216 | |||||||||||||||
balance-sheet.row.tax-assets | 644.07 | 279.9 | 117 | 137.8 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 3777.87 | 921.8 | 596.6 | 1075.3 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 42214.38 | 9081.9 | 7302.7 | 6032.9 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 69696.4 | 16336.1 | 12904.8 | 11492.3 | |||||||||||||||
balance-sheet.row.account-payables | 9244.98 | 2060.8 | 1621.2 | 1188.4 | |||||||||||||||
balance-sheet.row.short-term-debt | 5000.64 | 656.3 | 513.9 | 270.2 | |||||||||||||||
balance-sheet.row.tax-payables | 514.42 | 474 | 123.2 | 133.9 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 2224.33 | 215.1 | 513 | 10.5 | |||||||||||||||
Deferred Revenue Non Current | 1093.93 | 335 | 357.8 | 328.1 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 511.13 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 969.93 | 1027.3 | 216.3 | 28.3 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 3857.23 | 555.7 | 872.2 | 330.1 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 53.78 | 15 | 12.5 | 10.5 | |||||||||||||||
balance-sheet.row.total-liab | 22620.85 | 5405.8 | 3832.7 | 2569 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 6682.82 | 1670.7 | 1670.7 | 1203.7 | |||||||||||||||
balance-sheet.row.retained-earnings | 26988.46 | 5989.2 | 4306.2 | 4324.4 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 8525.75 | 989 | 808.9 | 640.9 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 4566.63 | 2283.3 | 2283.3 | 2750.3 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 46763.66 | 10932.2 | 9069.1 | 8919.3 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 69696.4 | 16336.1 | 12904.8 | 11492.3 | |||||||||||||||
balance-sheet.row.minority-interest | -40.48 | -1.9 | 3 | 4.1 | |||||||||||||||
balance-sheet.row.total-equity | 46723.18 | 10930.3 | 9072.2 | 8923.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 69696.4 | - | - | - | |||||||||||||||
Total Investments | 7657.84 | 1348.9 | 1 | 1 | |||||||||||||||
balance-sheet.row.total-debt | 7252.82 | 871.4 | 1026.9 | 270.2 | |||||||||||||||
balance-sheet.row.net-debt | 2294.75 | -1032.8 | 31.6 | -1066.8 |
Cash Flow kimutatás
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 453.79 | 2356.8 | 1341.6 | 1214.9 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 18.64 | 451.5 | 362.9 | 268.2 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -158.7 | 20.1 | -67.7 | |||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 158.7 | -20.1 | 67.7 | |||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 547.8 | -1309.7 | 24.8 | |||||||||||||||
cash-flows.row.account-receivables | 0 | -831.7 | -1280.3 | -668.7 | |||||||||||||||
cash-flows.row.inventory | 0 | -348 | -104.7 | -364.9 | |||||||||||||||
cash-flows.row.account-payables | 0 | 1886.2 | 55.1 | 1126.1 | |||||||||||||||
cash-flows.row.other-working-capital | 0 | -158.7 | 20.1 | -67.7 | |||||||||||||||
cash-flows.row.other-non-cash-items | -279.24 | 131.6 | 133.9 | 78.3 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -97.94 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -266.96 | -214 | -673.6 | -1144.8 | |||||||||||||||
cash-flows.row.acquisitions-net | -675.79 | 0.4 | 2.4 | 1145.1 | |||||||||||||||
cash-flows.row.purchases-of-investments | -2677.83 | -3461.9 | -451 | -2853.3 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 4232.64 | 1680.7 | 616.6 | 2957.6 | |||||||||||||||
cash-flows.row.other-investing-activites | 0.36 | 0 | -1.2 | -1144.8 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 612.43 | -1994.8 | -506.8 | -1040.2 | |||||||||||||||
cash-flows.row.debt-repayment | -651.63 | -2200 | -1469.9 | -270 | |||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | -1236.19 | -282.7 | -1220.1 | -244.1 | |||||||||||||||
cash-flows.row.other-financing-activites | 1548.01 | 1845.7 | 2387.9 | 490.8 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -344.34 | -637 | -302.1 | -23.3 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.6 | 1.2 | -0.5 | -2 | |||||||||||||||
cash-flows.row.net-change-in-cash | 168.43 | 857.2 | -280.7 | 520.8 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 4775.1 | 1810.7 | 953.5 | 1234.2 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 4606.67 | 953.5 | 1234.2 | 713.4 | |||||||||||||||
cash-flows.row.operating-cash-flow | -97.94 | 3487.7 | 528.7 | 1586.2 | |||||||||||||||
cash-flows.row.capital-expenditure | -266.96 | -214 | -673.6 | -1144.8 | |||||||||||||||
cash-flows.row.free-cash-flow | -364.9 | 3273.8 | -144.9 | 441.4 |
Eredménykimutatás sor
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 8836.76 | 12532.8 | 10116.8 | 8782.5 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 4301.71 | 4540.6 | 3681 | 3118.4 | |||||||||||||||
income-statement-row.row.gross-profit | 4535.05 | 7992.3 | 6435.8 | 5664.1 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 860.36 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 262.88 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1358.25 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | -42.42 | 576.9 | 366.6 | 323 | |||||||||||||||
income-statement-row.row.operating-expenses | 3928.53 | 5025.8 | 4758.7 | 4179.2 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 8230.24 | 9566.4 | 8439.7 | 7297.6 | |||||||||||||||
income-statement-row.row.interest-income | 22.9 | 12.9 | 20.4 | 7 | |||||||||||||||
income-statement-row.row.interest-expense | 42.41 | 33.8 | 34 | 3.8 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1358.25 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | -24.14 | -48.9 | -15.4 | -15.6 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | -42.42 | 576.9 | 366.6 | 323 | |||||||||||||||
income-statement-row.row.total-operating-expenses | -24.14 | -48.9 | -15.4 | -15.6 | |||||||||||||||
income-statement-row.row.interest-expense | 42.41 | 33.8 | 34 | 3.8 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 124.37 | 546.1 | 448.6 | 329.5 | |||||||||||||||
income-statement-row.row.ebitda-caps | 747 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | 620.63 | 2829.6 | 1569.1 | 1438 | |||||||||||||||
income-statement-row.row.income-before-tax | 596.49 | 2780.6 | 1553.7 | 1422.5 | |||||||||||||||
income-statement-row.row.income-tax-expense | 151.7 | 423.8 | 212.1 | 207.5 | |||||||||||||||
income-statement-row.row.net-income | 453.79 | 2361.8 | 1343.9 | 1218.7 |
Gyakran ismételt kérdés
Mi a Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) az összes eszköz?
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) az összes eszköz 16336112689.000.
Mekkora a vállalkozás éves bevétele?
Az éves bevétel 4197033558.000.
Mennyi a cég haszonkulcsa?
A cég haszonkulcsa 0.630.
Mennyi a vállalat szabad cash flow-ja?
A szabad pénzáramlás 0.986.
Mi a vállalati nettó haszonkulcs?
A nettó haszonkulcs 0.206.
Mennyi a vállalat teljes bevétele?
A teljes bevétel 0.243.
Mi a Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) nettó profit (nettó nyereség)?
A nettó nyereség (nettó bevétel) 2361804714.000.
Mennyi a cég teljes adóssága?
Az összes adósság 871449540.000.
Mi a működési költségek száma?
A működési költségek 5025828583.000.
Mennyi a cég készpénzállománya?
A vállalati pénzeszközök 1189759394.000.